The digital health company EverlyWell today announced that it has raised $50 million in funding led by its existing investor Goodwater Capital. CEO Julia Cheek founded EverlyWell in 2015 to offer validated at-home lab tests that are reviewed by physicians at a certified lab. In 2015, she started to feel sick and spent six months visiting specialists who ran a variety of lab tests to find out what was wrong. EverlyWell tests are available at Target, CVS, Humana and the EverlyWell website. Target began distributing EverlyWell test kits nationally earlier this month and currently offers nine products in more than 1,600 stores.

Source: Forbes April 16, 2019 21:19 UTC